American International Group, Inc. Viking Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.4 - $94.5 $46,492 - $252,504	2,672 Added 5.59%	50,466 $4.14 Million
Q4 2023 Feb 13, 2024	SELL	$9.24 - $19.64 $1,783 - $3,790	-193 Reduced 0.4%	47,794 $889,000
Q3 2023 Nov 13, 2023	BUY	$10.92 - $16.0 $18,640 - $27,312	1,707 Added 3.69%	47,987 $531,000
Q2 2023 Aug 04, 2023	BUY	$14.84 - $24.79 $686,795 - $1.15 Million	46,280 New	46,280 $750,000
Q2 2022 Aug 12, 2022	SELL	$2.11 - $3.15 $71,661 - $106,983	-33,963 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.0 - $4.88 $7,173 - $11,668	-2,391 Reduced 6.58%	33,963 $102,000
Q4 2021 Feb 11, 2022	SELL	$4.6 - $6.72 $5,000 - $7,304	-1,087 Reduced 2.9%	36,354 $167,000
Q3 2021 Nov 12, 2021	SELL	$5.58 - $7.04 $4,966 - $6,265	-890 Reduced 2.32%	37,441 $235,000
Q2 2021 Aug 13, 2021	BUY	$5.19 - $6.73 $602 - $780	116 Added 0.3%	38,331 $230,000
Q1 2021 May 07, 2021	BUY	$5.74 - $9.67 $579 - $976	101 Added 0.26%	38,215 $242,000
Q4 2020 Feb 12, 2021	SELL	$5.3 - $6.71 $5,792 - $7,334	-1,093 Reduced 2.79%	38,114 $215,000
Q3 2020 Nov 04, 2020	SELL	$5.73 - $8.11 $5,111 - $7,234	-892 Reduced 2.22%	39,207 $228,000
Q2 2020 Aug 12, 2020	BUY	$4.35 - $8.08 $7,325 - $13,606	1,684 Added 4.38%	40,099 $289,000
Q1 2020 May 04, 2020	SELL	$3.45 - $7.95 $7,655 - $17,641	-2,219 Reduced 5.46%	38,415 $180,000
Q4 2019 Feb 05, 2020	SELL	$6.38 - $8.73 $2,181 - $2,985	-342 Reduced 0.83%	40,634 $326,000
Q3 2019 Nov 08, 2019	SELL	$6.55 - $8.6 $1,866 - $2,451	-285 Reduced 0.69%	40,976 $282,000
Q2 2019 Aug 13, 2019	BUY	$7.67 - $10.63 $17,664 - $24,480	2,303 Added 5.91%	41,261 $342,000
Q1 2019 May 06, 2019	SELL	$7.58 - $9.94 $3,987 - $5,228	-526 Reduced 1.33%	38,958 $387,000
Q4 2018 Feb 13, 2019	BUY	$7.16 - $16.21 $36,379 - $82,363	5,081 Added 14.77%	39,484 $302,000
Q3 2018 Nov 09, 2018	BUY	$9.7 - $19.65 $58,549 - $118,607	6,036 Added 21.28%	34,403 $599,000
Q2 2018 Aug 08, 2018	BUY	$3.88 - $12.74 $110,063 - $361,395	28,367 New	28,367 $269,000

Others Institutions Holding VKTX

# of Institutions

473

Shares Held

66.2M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account